Complement: a unique innate immune sensor for danger signals

被引:418
作者
Gasque, P [1 ]
机构
[1] Univ Wales Coll Med, Dept Med Biochem & Immunol, BIIG, Cardiff CF144XN, S Glam, Wales
关键词
innate immunity; complement; phagocytosis; cytotoxicity; carbohydrates; apoptosis; clearance; scavenging; inflammation; repair;
D O I
10.1016/j.molimm.2004.06.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The complement (C) inflammatory cascade is part of the phylogenetically ancient innate immune response and is crucial to our natural ability to ward off infection. It has three critical physiologic activities: (i) defending against microbial infections by triggering the generation of a membranolytic complex (C5b9 complex) at the surface of the pathogen and C fragments (named opsonins, i.e., C1q, C3b and iC3b) which interact with C cell surface receptors (CR1, CR3 and CR4) to promote phagocytosis. Soluble C anaphylatoxins (C4a, C3a and C5a) greatly control the local pro-inflammatory response through the chemotaxis and activation of leukocytes; (ii) bridging innate and adaptive immunity (essentially through C receptor type 2, CR2, expressed by B cells) and (iii) disposing of immune complexes and the products of the inflammatory injury (i.e., other danger signals, e.g., toxic cell debris and apoptotic corpses) to ensure the protection and healing of the host. The regulatory mechanisms of C are finely balanced so that, on the one hand, the deposition of C is focused on the surface of invading microorganisms and, on the other hand, the deposition of C on normal cells is limited by several key C inhibitors (e.g., CD46, CD55 and CD59). Knowledge of the unique molecular and cellular innate immunological interactions that occur in the development and resolution of pathology should facilitate the design of effective therapeutic strategies to fight selectively against intruders. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1089 / 1098
页数:10
相关论文
共 84 条
[1]   Mechanisms of phagocytosis in macrophages [J].
Aderem, A ;
Underhill, DM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :593-623
[2]   Molecular cloning and characterization of the human anaphylatoxin C3a receptor [J].
Ames, RS ;
Li, Y ;
Sarau, HM ;
Nuthulaganti, P ;
Foley, JJ ;
Ellis, C ;
Zeng, ZZ ;
Su, K ;
Jurewicz, AJ ;
Hertzberg, RP ;
Bergsma, DJ ;
Kumar, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20231-20234
[3]   INVOLVEMENT OF ALPHA-2-MACROGLOBULIN AND C-REACTIVE PROTEIN IN A COMPLEMENT-LIKE HEMOLYTIC SYSTEM IN THE ARTHROPOD, LIMULUS-POLYPHEMUS [J].
ARMSTRONG, PB ;
ARMSTRONG, MT ;
QUIGLEY, JP .
MOLECULAR IMMUNOLOGY, 1993, 30 (10) :929-934
[4]   The major receptor for C-reactive protein on leukocytes is Fcγ receptor II [J].
Bharadwaj, D ;
Stein, MP ;
Volzer, M ;
Mold, C ;
Du Clos, TW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :585-590
[5]   Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies [J].
Botto, M ;
Dell'Agnola, C ;
Bygrave, AE ;
Thompson, EM ;
Cook, HT ;
Petry, F ;
Loos, M ;
Pandolfi, PP ;
Walport, MJ .
NATURE GENETICS, 1998, 19 (01) :56-59
[6]   C4b-binding protein (C4BP) activates B cells through the CD40 receptor [J].
Brodeur, SR ;
Angelini, F ;
Bacharier, LB ;
Blom, AM ;
Mizoguchi, E ;
Fujiwara, H ;
Plebani, A ;
Notarangelo, LD ;
Dahlback, B ;
Tsitsikov, E ;
Geha, RS .
IMMUNITY, 2003, 18 (06) :837-848
[7]  
Cabañas C, 1999, J BIOL REG HOMEOS AG, V13, P134
[8]   Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells [J].
Crass, T ;
Raffetseder, U ;
Martin, U ;
Grove, M ;
Klos, A ;
Kohl, J ;
Bautsch, W .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) :1944-1950
[9]   C3A IS A CHEMOTAXIN FOR HUMAN EOSINOPHILS BUT NOT FOR NEUTROPHILS .1. C3A STIMULATION OF NEUTROPHILS IS SECONDARY TO EOSINOPHIL ACTIVATION [J].
DAFFERN, PJ ;
PFEIFER, PH ;
EMBER, JA ;
HUGLI, TE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2119-2127
[10]   MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway [J].
Dahl, MR ;
Thiel, S ;
Matsushita, M ;
Fujita, T ;
Willis, AC ;
Christensen, T ;
Vorup-Jensen, T ;
Jensenius, JC .
IMMUNITY, 2001, 15 (01) :127-135